In this weeks Biotech Leader Spotlight Series we're recognizing Courtney Young, Cofounder and CEO of MyoGene Bio. Check out her interview to learn more about her all-female founded company!
Courtney Young is the CEO and Co-founder of MyoGene Bio, a biotech company developing a gene editing therapy, MyoDys45-55, for Duchenne muscular dystrophy (#DMD), a devastating muscle wasting disease. Dr. Young developed the gene editing approach that is the basis of MyoDys45-55 during her Ph.D. and postdoc in the Spencer and Pyle labs at UCLA. Her experience in muscle biology and diseases has spanned both academia and industry across the world. She has worked extensively in muscular dystrophy, stem cell therapy, and gene editing. Dr. Young graduated with a B.S. in Chemical and Biomolecular Engineering from The Johns Hopkins University, a Master of Research in Biomedicine from University College London, and a Ph.D. in Molecular Biology from UCLA.
#womeninbio #womeninscience #femalefounders #biotechleaders #biotechstartup #biotech #biotechnology #biopharma #therapeutics #drugdevelopment #musculardystrophy #pharmaceuticals